Home LiteratureArticle Details
PMID: 15908460 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Endothelin-1-induced contraction in veins is independent of hydrogen peroxide.

American journal of physiology. Heart and circulatory physiology ·Vol. 289 ·No. 3 ·2005-09-00 ·Pages H1115-22

Thakali K, Demel SL, Fink GD, Watts SW

Abstract

Reactive oxygen species (ROS), such as superoxide and H(2)O(2), are capable of modifying vascular tone, although the response to ROS can vary qualitatively among vascular beds, experimental procedures, and species. Endothelin-1 (ET-1) induces superoxide production, which can be dismutated to H(2)O(2). The RhoA/Rho kinase pathway partially mediates ET-1-induced contraction and recently was implicated in superoxide-induced contraction. We hypothesized that H(2)O(2), not superoxide, mediates venous ET-1-induced contraction. Rat thoracic aorta and vena cava contracted to exogenously added H(2)O(2) (1 microM-1 mM) [maximum aortic contraction = 10 +/- 3% of phenylephrine (10 microM) contraction; maximum venous contraction = 85 +/- 13% of norepinephrine (10 microM) contraction]. (+)-(R)-trans-4-(1-aminoethyl-N-4-pyridil)cyclohexanecarboxamide dihydrochloride (Y-27632, 10 microM), a Rho kinase inhibitor, significantly reduced venous H(2)O(2)-induced contraction (15 +/- 1% of control maximum) and reduced maximum ET-1-induced contraction by 59 +/- 1%. However, neither the H(2)O(2) scavenger catalase (100 and 2,000 U/ml) nor cell permeable polyethylene glycol-catalase (163 and 326 U/ml) reduced ET-1-induced contraction in the vena cava. The catalase inhibitor 3-aminotriazole (3-AT) also had no effect on maximal venous ET-1-induced contraction. Basal H(2)O(2) levels were three times higher in the vena cava than in the aorta (vena cava, 0.74 +/- 0.09 nmol H(2)O(2)/mg protein; aorta, 0.24 +/- 0.05 nmol H(2)O(2)/mg protein). ET-1 (100 nM) increased H(2)O(2) in the vena cava but not in the aorta (vena cava, 154.10 +/- 17.29% of control H(2)O(2); aorta, 83.72 +/- 20.20%). Antagonism of either ET(A) or ET(B) receptors with the use of atrasentan (30 nM) or BQ-788 (100 nM), respectively, reduced ET-1 (100 nM)-induced increases in venous H(2)O(2). In summary, ET-1 increased H(2)O(2) in veins but not arteries, and venous ET-1-induced H(2)O(2) production was independent of the contractile properties of ET-1.

MeSH Terms
Animals Aorta, Thoracic/physiology Endothelin-1/pharmacology Hydrogen Peroxide/metabolism,pharmacology Intracellular Signaling Peptides and Proteins Male Muscle, Smooth, Vascular/drug effects,physiology Myosin-Light-Chain Phosphatase/metabolism NADPH Oxidases/metabolism Oxidants/metabolism,pharmacology Phosphorylation Protein Serine-Threonine Kinases/metabolism Rats Rats, Sprague-Dawley Reactive Oxygen Species/metabolism Vasoconstriction/drug effects Vena Cava, Inferior/drug effects,physiology rho-Associated Kinases rhoA GTP-Binding Protein/metabolism
Chemicals
Endothelin-1 Intracellular Signaling Peptides and Proteins Oxidants Reactive Oxygen Species Hydrogen Peroxide NADPH Oxidases Protein Serine-Threonine Kinases rho-Associated Kinases Myosin-Light-Chain Phosphatase rhoA GTP-Binding Protein
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Thakali Keshari
Department of Pharmacology and Toxicology, Michigan State University, E. Lansing, MI 48824-1317, USA. thakalik@msu.edu
Demel Stacie L
Fink Gregory D
Watts Stephanie W
Article Info
Journal
American journal of physiology. Heart and circulatory physiology
Abbr.
Am J Physiol Heart Circ Physiol
ISSN
0363-6135
Published
2005-09-00
Epub
2005-00-20
Pages
H1115-22
Language
English
Region
United States
NLM ID
100901228
Subset
IM
Grants
NHLBI NIH HHS · P01 HL-70687 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com